Yes, Old World Stocks Are Starting to Look Like the Smarter Bet in This Mania
You’ve hit on the exact tension I’ve been mulling over lately. It’s that classic late-stage technology buildout dilemma: the staggering gap between capital consumed today and actual cash generated tomorrow.
We are living through the largest infrastructure sprint in human history. The aggregate 2026 capital expenditure (CapEx) for just the top tech giants is tracking toward $660 billion to $690 billion, on its way to a global $1 trillion cloud buildout. The market has funded this on absolute faith, pricing in pristine margins and flawless execution. But while the infrastructure layer is raking it in, the actual software and enterprise AI revenue moving the needle is just a fraction of that spend. If enterprise adoption hits even a minor speed bump, that massive CapEx turns into a heavy depreciation drag on earnings, forcing a brutal re-rating.
Meanwhile, the market has treated the bedrock of the real economy like forgotten relics. By stepping away from the AI noise, we can find incredible asymmetry in businesses that don't require a leap of faith.
The Valuation Disconnect: Hype vs. Reality
To see just how stark this dispersion has become, we only have to look at the numbers. We are seeing premium tech names trading at nosebleed multiples on the promise of hyper-growth, while cash-rich, defensive compounders are sitting at incredibly reasonable valuations despite their massive structural moats.
Company / SectorForward P/E MultipleFree Cash Flow (FCF) YieldThe Market Narrative
The AI Vanguard35x – 45x+~2.0% – 2.5%Priced for absolute perfection. Assumes exponential software monetization and zero margin compression from rising energy or chip costs.
Costco (COST)48x – 50x~2.0%Exceptionally high quality, but priced like a tech stock due to its bulletproof membership model and foot traffic consistency.
Procter & Gamble (PG)24x – 25x~4.5%Forgotten. The market worries about raw material costs, but ignores their immense pricing power and centuries of brand loyalty.
McDonald's (MCD)21x – 22x~5.0%Temporarily out of favor due to global low-income consumer headwinds, making it a highly attractive entry point for a global real estate and franchise king.
Johnson & Johnson (JNJ)14x – 15x~6.5%Deeply discounted. Trading near rock-bottom multiples due to legacy litigation noise, completely ignoring their predictable healthcare pipeline and dividend king status.
When you contrast a healthcare giant or a consumer staple trading at 15x to 24x earnings against AI infrastructure trading at 40x, the risk-reward completely flips. You aren't betting against innovation by looking at the left side of the ledger; you’re just refusing to pay a historic premium for it.
Why the Counter-Trade Works
The beauty of this rotation is that it relies on things that are entirely knowable. You don't need to accurately forecast the exact quarter enterprise AI finally moves the needle on corporate balance sheets. You just need to bet on the continuity of daily life.
Capital Discipline: Tech is trapped in a CapEx arms race—they have to spend billions just to maintain their competitive positioning. The old guard spends modestly on supply chains and handsomely rewards shareholders.
True Moats: Brand inelasticity is a powerful thing. People will grumble about inflation, but they will still pay an extra 50 cents for their preferred toothpaste, buy their groceries in bulk, and pick up a quick meal.
The Yield Cushion: In an environment where interest rates stay higher for longer, steady, growing dividend streams and robust free cash flow yields (like JNJ’s ~6.5% or P&G's ~4.5%) provide a massive margin of safety that tech simply cannot offer.
Managing the Rotation
Executing a thoughtful shift like this isn't about calling the exact day the tech cycle tops out—that's a fool's errand. It’s about recognizing when the rubber band has stretched too far.
When capital markets eventually experience a regime shift—whether triggered by a disappointing tech earnings season or broader macroeconomic jitters—money will move defensively. It will flee the companies that consume cash to chase growth and flood right back into the businesses that reliably generate cash out of thin air. By locking in exposure to these steady compounders while they are out of favor, you're positioned perfectly for when the growth names inevitably catch a cold.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
